164 related articles for article (PubMed ID: 22624027)
1. Cervical, anal and oral HPV in an adolescent inner-city health clinic providing free vaccinations.
Schlecht NF; Burk RD; Nucci-Sack A; Shankar V; Peake K; Lorde-Rollins E; Porter R; Linares LO; Rojas M; Strickler HD; Diaz A
PLoS One; 2012; 7(5):e37419. PubMed ID: 22624027
[TBL] [Abstract][Full Text] [Related]
2. Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection.
Beachler DC; Kreimer AR; Schiffman M; Herrero R; Wacholder S; Rodriguez AC; Lowy DR; Porras C; Schiller JT; Quint W; Jimenez S; Safaeian M; Struijk L; Schussler J; Hildesheim A; Gonzalez P;
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26467666
[TBL] [Abstract][Full Text] [Related]
3. Risk of Delayed Human Papillomavirus Vaccination in Inner-City Adolescent Women.
Schlecht NF; Diaz A; Shankar V; Szporn AH; Wu M; Nucci-Sack A; Peake K; Strickler HD; Burk RD
J Infect Dis; 2016 Dec; 214(12):1952-1960. PubMed ID: 27738056
[TBL] [Abstract][Full Text] [Related]
4. Risk of Oral Human Papillomavirus Infection Among Sexually Active Female Adolescents Receiving the Quadrivalent Vaccine.
Schlecht NF; Masika M; Diaz A; Nucci-Sack A; Salandy A; Pickering S; Strickler HD; Shankar V; Burk RD
JAMA Netw Open; 2019 Oct; 2(10):e1914031. PubMed ID: 31651968
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of cervical, oral, and anal human papillomavirus infection in women living with HIV in Denmark - The SHADE cohort study.
Thorsteinsson K; Storgaard M; Katzenstein TL; Ladelund S; Rönsholt FF; Johansen IS; Pedersen G; Gaardsting A; Nielsen LN; Bonde J; Lebech AM
J Clin Virol; 2018 Aug; 105():64-71. PubMed ID: 29906660
[TBL] [Abstract][Full Text] [Related]
6. Oral human papillomavirus (HPV) infection in men who have sex with men: prevalence and lack of anogenital concordance.
King EM; Gilson R; Beddows S; Soldan K; Panwar K; Young C; Jit M; Edmunds WJ; Sonnenberg P
Sex Transm Infect; 2015 Jun; 91(4):284-6. PubMed ID: 25887283
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of human papillomavirus in young men who have sex with men after the implementation of gender-neutral HPV vaccination: a repeated cross-sectional study.
Chow EPF; Tabrizi SN; Fairley CK; Wigan R; Machalek DA; Garland SM; Cornall AM; Atchison S; Hocking JS; Bradshaw CS; Balgovind P; Murray GL; Chen MY
Lancet Infect Dis; 2021 Oct; 21(10):1448-1457. PubMed ID: 34043963
[TBL] [Abstract][Full Text] [Related]
8. Incidence and Types of Human Papillomavirus Infections in Adolescent Girls and Young Women Immunized With the Human Papillomavirus Vaccine.
Schlecht NF; Diaz A; Nucci-Sack A; Shyhalla K; Shankar V; Guillot M; Hollman D; Strickler HD; Burk RD
JAMA Netw Open; 2021 Aug; 4(8):e2121893. PubMed ID: 34424304
[TBL] [Abstract][Full Text] [Related]
9. Monitoring for Human Papillomavirus Vaccine Impact Among Gay, Bisexual, and Other Men Who Have Sex With Men-United States, 2012-2014.
Meites E; Gorbach PM; Gratzer B; Panicker G; Steinau M; Collins T; Parrish A; Randel C; McGrath M; Carrasco S; Moore J; Zaidi A; Braxton J; Kerndt PR; Unger ER; Crosby RA; Markowitz LE
J Infect Dis; 2016 Sep; 214(5):689-96. PubMed ID: 27296847
[TBL] [Abstract][Full Text] [Related]
10. Oral human Papillomavirus DNA detection in HIV-positive men: prevalence, predictors, and co-occurrence at anal site.
Vergori A; Garbuglia AR; Piselli P; Del Nonno F; Sias C; Lupi F; Lapa D; Baiocchini A; Cimaglia C; Gentile M; Antinori A; Capobianchi M; Ammassari A
BMC Infect Dis; 2018 Jan; 18(1):25. PubMed ID: 29310590
[TBL] [Abstract][Full Text] [Related]
11. Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1.
Cespedes MS; Kang M; Kojic EM; Umbleja T; Godfrey C; Webster-Cyriaque JY; Masih R; Firnhaber C; Grinsztejn B; Saah A; Cu-Uvin S; Aberg JA
Papillomavirus Res; 2018 Dec; 6():15-21. PubMed ID: 30118852
[TBL] [Abstract][Full Text] [Related]
12. Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine.
Ährlund-Richter A; Cheng L; Hu YOO; Svensson M; Pennhag AAL; Ursu RG; Haeggblom L; Grün N; Ramqvist T; Engstrand L; Dalianis T; Du J
Front Cell Infect Microbiol; 2019; 9():59. PubMed ID: 30949454
[No Abstract] [Full Text] [Related]
13. Pre-vaccination prevalence of anogenital and oral human papillomavirus in young HIV-infected men who have sex with men.
Kahn JA; Belzer M; Chi X; Lee J; Gaur AH; Mayer K; Martinez J; Futterman DC; Stier EA; Paul ME; Chiao EY; Reirden D; Goldstone SE; Ortiz Martinez AP; Cachay ER; Barroso LF; Da Costa M; Wilson CM; Palefsky JM;
Papillomavirus Res; 2019 Jun; 7():52-61. PubMed ID: 30658128
[TBL] [Abstract][Full Text] [Related]
14. Reduced prevalence of vulvar HPV16/18 infection among women who received the HPV16/18 bivalent vaccine: a nested analysis within the Costa Rica Vaccine Trial.
Lang Kuhs KA; Gonzalez P; Rodriguez AC; van Doorn LJ; Schiffman M; Struijk L; Chen S; Quint W; Lowy DR; Porras C; DelVecchio C; Jimenez S; Safaeian M; Schiller JT; Wacholder S; Herrero R; Hildesheim A; Kreimer AR;
J Infect Dis; 2014 Dec; 210(12):1890-9. PubMed ID: 24958910
[TBL] [Abstract][Full Text] [Related]
15. Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy.
Carozzi F; Puliti D; Ocello C; Anastasio PS; Moliterni EA; Perinetti E; Serradell L; Burroni E; Confortini M; Mantellini P; Zappa M; Dominiak-Felden G
BMC Infect Dis; 2018 Jan; 18(1):38. PubMed ID: 29334901
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of Any and Vaccine-Type Anogenital Human Papillomavirus Among 13-26-Year-Old Young Men After HPV Vaccine Introduction.
Chandler E; Ding L; Gorbach P; Franco EL; Brown DA; Widdice LE; Bernstein DI; Kahn JA
J Adolesc Health; 2018 Jul; 63(1):43-49. PubMed ID: 30060856
[TBL] [Abstract][Full Text] [Related]
17. Low prevalence of vaccine-type HPV infections in young women following the implementation of a school-based and catch-up vaccination in Quebec, Canada.
Goggin P; Sauvageau C; Gilca V; Defay F; Lambert G; Mathieu-C S; Guenoun J; Comète E; Coutlée F
Hum Vaccin Immunother; 2018 Jan; 14(1):118-123. PubMed ID: 29049007
[TBL] [Abstract][Full Text] [Related]
18. Vaccine Effectiveness Against Prevalent Anal and Oral Human Papillomavirus Infection Among Men Who Have Sex With Men-United States, 2016-2018.
Meites E; Winer RL; Newcomb ME; Gorbach PM; Querec TD; Rudd J; Collins T; Lin J; Moore J; Remble T; Swanson F; Franz J; Bolan RK; Golden MR; Mustanski B; Crosby RA; Unger ER; Markowitz LE
J Infect Dis; 2020 Nov; 222(12):2052-2060. PubMed ID: 32504091
[TBL] [Abstract][Full Text] [Related]
19. Non-Vaccine-Type Human Papillomavirus Prevalence After Vaccine Introduction: No Evidence for Type Replacement but Evidence for Cross-Protection.
Saccucci M; Franco EL; Ding L; Bernstein DI; Brown D; Kahn JA
Sex Transm Dis; 2018 Apr; 45(4):260-265. PubMed ID: 29465705
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.
Figueroa JP; Ward E; Luthi TE; Vermund SH; Brathwaite AR; Burk RD
Sex Transm Dis; 1995; 22(2):114-8. PubMed ID: 7624812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
